SLC12A2 and neoplasm: Tumor-derived exosomal SLC12A2-DT (divergent transcript of SLC12A2) promotes HCC progression by regulating the interaction between HCC cells and TAMs via the Wnt/GSK3β/β-catenin signaling pathway [39].